As a result, Cooper et al. suggested testosterone treatment may attenuate muscle loss and possibly bone loss after SCI (59, 60). TRT + finasteride produced anticipated hormonal responses, evidenced by higher total testosterone (+460 ± 115%) and lower dihydrotestosterone (−49 ± 17%) vs. baseline, across timepoints. Specifically, five of seven TRT + finasteride participants exhibited nadir total testosterone above the reference range upper limit (869 ng/dL), necessitating TRT dose adjustment based on our a priori criteria. However, the incidence of total testosterone, dihydrotestosterone, and estradiol concentrations outside standard reference ranges was more than double in TRT + finasteride vs. vehicle+placebo. Baseline total testosterone was 291 ± 135 ng/dL (TRT + finasteride) vs. 280 ± 120 ng/dL (vehicle+placebo). TRT, testosterone replacement therapy; KE, knee extensor; CSA, cross-sectional area; MVIC, maximal voluntary isometric contraction; aBMD, areal bone mineral density; L2-L4, lumbar spine vertebrae 2–4; CTX, type I collagen cross-linked C-telopeptide; TRAcP 5b, tartrate-resistant acid phosphatase 5b (derived from osteoclasts). In the spine, reduced bone density increases the risk of vertebral compression, posture changes, and long-term discomfort. This may lead to osteopenia or osteoporosis, conditions where bones become weaker and more likely to develop tiny fractures. Testosterone supports the continual rebuilding and strengthening of bone tissue. Some people also notice changes in posture because the muscles cannot support the spine as well as before, which can further increase discomfort. This added strain can lead to mechanical back pain, especially during lifting, bending, or long periods of sitting or standing. When these muscles lose strength or endurance, the spine must carry more of the load. When levels become too low, these systems can weaken, which may place extra strain on the spine. Sections were incubated for 15 minutes in 0.5% (v/v) H2O2 diluted in methanol, rinsed in PBS and incubated with a solution of 1% (w/v) bovine serum albumin (BSA) in PBS for 10 minutes toprevent non-specific binding of the primary antibody. The proportions of spermatozoa with increased levels of red and green fluorescence were determined by computer gates. The follow-up experiment was performed during the acute (a time point at which impaired sperm motility was not related to the extent of cord injury) and chronic (a time point at which impaired sperm motility was inversely correlated with the extent of injury) phases of SCI. Animals that received testosterone immediately after SCI for a 35-day period and were killed 24 hours after the last testosterone injection on day 35 post-injury (SCIT35), iii. Animals that received testosterone one week after SCI and were killed 24 hours after last testosterone injection on day day 14 post-injury (SCI-T7), iv. Animals that received testosterone (Sigma Chem. Co., Germany, Cat. No. T1500) for 7 days immediately after SCI and were killed 24 hours after the last testosterone injection on day 7 post-injury (SCIT7),iii. Prevention of some of these abnormalities during early phase of SCI and maintenance of qualitatively complete spermatogenesis during the chronic phase of SCI, have been investigated by different studies. This does not mean low testosterone is the only cause of back pain, but it may be a contributing factor for some individuals. Because these systems are closely tied to how the spine functions, it makes sense that people often wonder whether low testosterone could be linked to back pain. Testosterone plays several important roles in muscle strength, bone density, and overall physical stability. Most healthcare providers schedule blood tests at the beginning of treatment, again a few months later, and then at regular intervals. This is because external testosterone signals the body to reduce natural hormone production needed for sperm creation. Higher testosterone levels can increase oil production in the skin. InflammationChronic inflammation may increase joint stiffness and muscle pain. Based on serum testosterone level of SCI35 group, the relatively normal function of the pituitary-testis hormone axis was restored in the chronic phase of SCI. Effect of spinal cord injury (SCI) and testosterone treatment on the descriptive feature of cell adhesion molecule-1 (CADM1). Effect of spinal cord injury (SCI) and testosterone treatment on the expression and transcription level of cell adhesion molecule-1 (CADM1) Effect of spinal cord injury (SCI) and testosterone treatment on germinal epithelium Interestingly, thechronic phase of SCI (35 days after injury) did notshow a significant reduction in testosterone level. Intramuscular testosterone moderately increased lumbar bone spine density in men, but the effects on femoral neck density were uncertain. In conclusion, testosterone therapy shows promise as a treatment for back pain, but it's important to understand both its benefits and risks. It is important to find a healthcare provider who is experienced with testosterone therapy. Starting testosterone therapy for back pain can be a detailed process. Even if someone believes they have low testosterone, red-flag symptoms must be taken seriously and checked right away. Rapid or unexplained weight loss along with back pain may indicate inflammation, infection, or in rare cases, cancer. Some symptoms should never be ignored, even if someone also suspects low testosterone. For many people, back pain comes from structural or mechanical issues in the spine, joints, or nerves.
